M&T Bank Corp Has $937,000 Holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

M&T Bank Corp lifted its position in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 2.8% during the third quarter, Holdings Channel.com reports. The firm owned 50,335 shares of the real estate investment trust’s stock after purchasing an additional 1,374 shares during the period. M&T Bank Corp’s holdings in Sabra Health Care REIT were worth $937,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of SBRA. Nisa Investment Advisors LLC raised its holdings in Sabra Health Care REIT by 3.0% during the second quarter. Nisa Investment Advisors LLC now owns 127,738 shares of the real estate investment trust’s stock worth $1,967,000 after buying an additional 3,667 shares during the last quarter. Van Lanschot Kempen Investment Management N.V. raised its holdings in shares of Sabra Health Care REIT by 461.0% in the 2nd quarter. Van Lanschot Kempen Investment Management N.V. now owns 563,844 shares of the real estate investment trust’s stock worth $8,683,000 after acquiring an additional 463,344 shares during the last quarter. Family Firm Inc. bought a new position in Sabra Health Care REIT in the 2nd quarter valued at about $26,000. LDR Capital Management LLC boosted its stake in Sabra Health Care REIT by 4.7% during the 2nd quarter. LDR Capital Management LLC now owns 454,219 shares of the real estate investment trust’s stock valued at $6,995,000 after purchasing an additional 20,554 shares during the last quarter. Finally, Arkadios Wealth Advisors acquired a new position in Sabra Health Care REIT during the 2nd quarter valued at about $305,000. 99.40% of the stock is currently owned by institutional investors.

Sabra Health Care REIT Stock Performance

NASDAQ SBRA opened at $17.50 on Monday. The company has a market capitalization of $4.14 billion, a PE ratio of 42.68, a price-to-earnings-growth ratio of 2.20 and a beta of 1.24. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.16 and a current ratio of 4.16. Sabra Health Care REIT, Inc. has a 52-week low of $12.83 and a 52-week high of $20.03. The company has a 50-day simple moving average of $18.52 and a 200 day simple moving average of $17.11.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by ($0.22). Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. The company had revenue of $178.00 million for the quarter, compared to analysts’ expectations of $177.19 million. During the same quarter in the previous year, the business earned $0.34 EPS. On average, research analysts predict that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current year.

Sabra Health Care REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 29th. Shareholders of record on Friday, November 15th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.86%. Sabra Health Care REIT’s payout ratio is presently 292.69%.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on SBRA. Mizuho restated a “neutral” rating and issued a $20.00 target price on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Citigroup upgraded Sabra Health Care REIT from a “neutral” rating to a “buy” rating and raised their price objective for the company from $17.00 to $20.00 in a research note on Friday, September 13th. Scotiabank upped their target price on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a “sector perform” rating in a research note on Friday, October 11th. Wells Fargo & Company upgraded shares of Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $16.00 to $20.00 in a research note on Tuesday, October 1st. Finally, Truist Financial boosted their target price on Sabra Health Care REIT from $16.00 to $18.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $19.14.

Sabra Health Care REIT Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.